Tafinlar 00078-0682-66
Generic: Dabrafenib
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 12, 2016
- Listing Expires
- December 31, 2027
- Application
- NDA202806
Need to source Tafinlar? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dabrafenib Mesylate | 50 mg/1 |
Drug Class
Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2B6 Inducers [MoA]Cytochrome P450 2C19 Inducers [MoA]
Selected Package
00078-0682-66Selected120 CAPSULE in 1 BOTTLE (0078-0682-66)